Showing results (881-890 of 2,158) with videos related to
Sort By:
Pageof 216
Journal of Biopharmaceutical Statistics|September 21, 2020
TEPI-2 and UBI: designs for optimal immuno-oncology and cell therapy dose finding with toxicity and efficacyPin Li, Rachael Liu, Jianchang Lin, et al.Journal of Biopharmaceutical Statistics|December 7, 2020
Bayesian joint modeling for partially linear mixed-effects quantile regression of longitudinal and time-to-event data with limit of detection, covariate measurement errors and skewnessHanze Zhang, Yangxin HuangJournal of Biopharmaceutical Statistics|July 6, 2022
Risk difference, relative risk, and odds ratio for non-inferiority clinical trials with risk rate endpointSenmiao Ni, Quanji Yu, Zihang Zhong, et al.Journal of Biopharmaceutical Statistics|July 6, 2022
A randomized Bayesian optimal phase II design with binary endpointYang DingJournal of Biopharmaceutical Statistics|December 9, 2020
Evidence inconsistency degrees of freedom in Bayesian network meta-analysisLifeng LinJournal of Biopharmaceutical Statistics|May 16, 2022
Survival stacking with multiple data types using pseudo-observation-based-AUC lossPablo Gonzalez Ginestet, Erin E Gabriel, Michael C SachsJournal of Biopharmaceutical Statistics|May 23, 2022
Optimal sample size determination for single-arm trials in pediatric and rare populations with Bayesian borrowingZiyu Ji, Junjing Lin, Jianchang LinJournal of Biopharmaceutical Statistics|January 1, 1991
Nonparametric tests for interaction and group differences in a two-way layoutA C Fisher, S WallensteinJournal of Biopharmaceutical Statistics|August 30, 2019
High dimensional surrogacy: computational aspects of an upscaled analysisRudradev Sengupta, Nolen Joy Perualila, Ziv Shkedy, et al.Journal of Biopharmaceutical Statistics|September 10, 2019
Benefit-risk assessment for binary diagnostic testsTianyu Bai, Lan Huang, Meijuan Li, et al.Pageof 216